Mangoceuticals, Inc. is focused on developing men’s and women’s health and wellness products and services via a secure telemedicine platform. The Company connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com, for the provision of care via telehealth on its customer portal. It has developed and is commercially marketing a brand of erectile dysfunction (ED) products under the brand name Mango, a brand of hair-loss products under the brand name Grow, a brand of hormone balance and therapy products under the name Mojo, and a brand of weight-loss products under the brand name Slim. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin. Mango GROW includes four ingredients: Minoxidil (the active ingredient in Rogaine) and Finasteride (the active ingredient in Propecia), Vitamin D3 and Biotin, which are available as dietary supplements.
Símbolo de cotizaciónMGRX
Nombre de la empresaMangoceuticals Inc
Fecha de salida a bolsaMar 21, 2023
Director ejecutivoCohen (Jacob D)
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 21
Dirección15110 Dallas Pkwy, Suite 600
CiudadDALLAS
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal75248
Teléfono18336264679
Sitio Webhttps://www.mangorx.com/
Símbolo de cotizaciónMGRX
Fecha de salida a bolsaMar 21, 2023
Director ejecutivoCohen (Jacob D)
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos